Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism

Haematologica

Volumn 87, Issue 10, 2002, Pages 1068-1073

  Libourel, Eduard J ^a   Bank, Ivan ^a   Meinardi, Johan R ^a   Baljé Volkers, Corine P ^a   Hamulyak, Karly ^a   Middeldorp, Saskia ^a   Koopman, Maria M W ^a   Van Pampus, Elisabeth C M ^a   Prins, Martin H ^a   Büller, Harry R ^a   Der Meer, Jan Van ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Factor VIII:C; Factor XI:C; TAFI, lipoprotein (a); Venous thrombosis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; LIPOPROTEIN A; PROTEIN C; PROTEIN S; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEGREGATION; GENETIC RISK; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; CARBOXYPEPTIDASE U; COHORT STUDIES; FACTOR V; FACTOR VIII; FACTOR XI; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; RISK FACTORS; THROMBOSIS; VENOUS THROMBOSIS;

EID: 0036797501     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76:651-62.
2. Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Eng J Med 1994; 330:517-22.
3. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, De Ronde H et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-7.
4. Middeldorp S, Henkens CM, Koopman MM, Van Pampus EC, Hamulyak K, Van der Meer J, et al. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Ann Intern Med 1998; 128:15-20.
5. Lensen RP, Bertina RM, De Ronde H, Vandenbroucke JP, Rosendaal FR. Venous thrombotic risk in family members of unselected individuals with factor V Leiden. Thromb Haemost 2000; 83:817-21.
6. Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost 1997; 78:297-301.
7. Van Boven HH, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, et al. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 1996; 75:417-21.
8. Koeleman BP, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 84:1031-5.
9. Zoller B, Berntsdotter A, Garcia de Frutos P, Dahlback B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995; 85:3518-23.
10. Meinardi JR, Middeldorp S, De Kam PJ, Koopman MM, Van Pampus EC, Hamulyak K, et al. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: A retrospective analysis; Blood Coagul Fibrinolysis 2001; 12:713-20.
11. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342:696-701.
12. Van Tilburg NH, Rosendaal FR, Bertina RM. Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood 2000; 95:2855-9.
13. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apoliprotein (a) is homologous to plasminogen. Nature 1987; 300:132-7.
14. von Depka M, Nowak-Göttl U, Eisert R, Dieterich C, Barthels M, Scharrer I, et al. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood 2000; 96:3364-8.
15. Nowak-Göttl U, Junker R, Hartmeier M, Koch HG, Munchow N, Assmann G, et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999; 100:743-8.
16. Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 1996; 143:1257-65.
17. Danneberg J, Abbes AP, Bruggeman BJ, Engel H, Gerrits J, Martens A. Reliable genotyping of the G-20210-A mutation of coagulation factor II (prothrombin). Clin Chem 1998; 44:349-51.
18. Schatteman KA, Goossens FJ, Scharpé SS, Neels HM, Hendriks DF. Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma. Clin Chem 1999; 45:807-13.
19. Lensen R, Bertina RM, Vandenbroucke JP, Rosendaal FR. High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden. Br J Haematol 2001; 114:380-6.
20. Libourel EJ, Bank I, Hamulyak K, Middeldorp S, Büller HR, Van der Meer J. Elevated lipoprotein (a) levels, not a risk factor for venous thromboembolism. Thromb Hemost 2001; 86:P1402[abstract].
21. Lippi G, Bassi A, Brocco G, Manzato F, Marini M, Guidi G. Lipoprotein(a) concentration is not associated with venous thromboembolism in a case control study. Haematologica 1999; 84:726-9.
22. März W, Trommlitz M, Scharrer I, Gross W. Apolipoprotein (a) concentrations are not related to the risk of venous thrombosis. Blood Coagul Fibrinolysis 1991; 2:595-9.
23. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232:155-60.